Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

247.81 -15.92 (-6.04%)
Delayed Quote Updated: 3:06 PM EDT, Oct 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Johnson & Johnson

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Explore the top gainers and losers within the dow jones index in today's session. ↗
Via Chartmill
These S&P500 stocks are moving in today's session ↗
Via Chartmill
News headline image
Why Johnson & Johnson Stock Dropped Today ↗
Johnson & Johnson beat earnings this morning. Then its stock price dropped. 
Via The Motley Fool
Topics Earnings
News headline image
Surgical Precision, Sustainable Returns: Johnson & Johnson Secures its Cash Flow Runway ↗
Johnson & Johnson posted Q3 revenue growth of 5.9% to $25.4 billion, raised guidance, and gained analyst support as its OTTAVA surgical system and talc settlement shape its long-term outlook. 
Via MarketBeat
Johnson & Johnson (NYSE:JNJ) Q3 2026: In-Line Results and Raised Guidance Offset by MedTech Weakness ↗
Via Chartmill
Johnson & Johnson (NYSE:JNJ): Dividend Quality Makes It a Durable Income Pick ↗
Via Chartmill
Discover which dow jones stocks are making waves on Tuesday. ↗
Via Chartmill
Explore the top gainers and losers within the S&P500 index in today's session. ↗
Via Chartmill
News headline image
Stock Market Midday, Oct. 13: Bank Earnings and Chip Pressure Drive Mixed Trading ↗
Goldman Sachs gains on strong revenue while Johnson & Johnson stumbles on earnings miss, today, Oct. 13, 2026. 
Via The Motley Fool
Topics Earnings Stocks
News headline image
What Johnson & Johnson (JNJ) Said on Its Q3 Earnings Call ↗
Johnson & Johnson (NYSE:JNJ) reported third-quarter 2026 worldwide sales of $25.4 billion, up 6% operationally from a year earlier, as growth in its Innovative Medicine business offset... 
Via MarketBeat
Topics Earnings
These S&P500 stocks are gapping in today's session ↗
Via Chartmill
News headline image
Health Bellwether J&J Slumps As Middle East Conflict Hampers Medtech Sales ↗
Johnson & Johnson stock fell early Tuesday as the conflict in the Middle East weighted on medical device sales. 
Via Investor's Business Daily
News headline image
Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2026
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson reports Q3 2026 results, raises 2026 guidance
From Johnson & Johnson
Via Business Wire
News headline image
Want Passive Income for Life? Here Are 2 Dividend Stocks to Buy and Never Sell ↗
These companies have a long history of dividend growth. 
Via The Motley Fool
News headline image
Johnson & Johnson vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026? ↗
Johnson & Johnson trades at a higher valuation with growing sales, while Pfizer's dividend yield is near 6% as patents expire from 2026 through 2030. 
Via The Motley Fool
Topics Intellectual Property
News headline image
How Much Would You Need to Invest in These 5 Pharma Stocks to Earn $1,000 a Month in Dividends? ↗
You'll need to generate $12,000 a year in dividends to average $1k per month from Amgen, Pfizer, J&J, AbbVie, and Bristol Myers Squibb. 
Via The Motley Fool
Topics Intellectual Property
News headline image
2 Dividend Stocks Worth Holding Forever (Including 1 Dividend King) ↗
A 50-year dividend grower and a monthly income REIT; how J&J and Realty Income build lasting wealth for patient investors. 
Via The Motley Fool
Friday's session: top gainers and losers in the dow jones index ↗
Via Chartmill
Top dow jones movers in Friday's session ↗
Via Chartmill
News headline image
Bristol Myers Squibb vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026? ↗
Both face patent cliffs and regulatory headwinds, but their balance sheets and cash generation tell starkly different stories. 
Via The Motley Fool
Topics Intellectual Property
These dow jones stocks are moving in today's session ↗
Via Chartmill
News headline image
Prediction: Johnson & Johnson Will Be a Faster-Growing Company by 2030 Than Most Investors Expect ↗
Don't underestimate this healthcare giant. 
Via The Motley Fool
News headline image
DocMagic’s Lori Johnson named a 2026 Powerful Woman of Mortgage Banking
TORRANCE, Calif., Oct. 8, 2026 (SEND2PRESS NEWSWIRE) -- DocMagic® announced today that Chief Operating Officer Lori Johnson has been named one of Mortgage Banker's 2026 Powerful Women of Mortgage... 
Via Send2Press
Top dow jones movers in Wednesday's session ↗
Via Chartmill
Which dow jones stocks are moving on Wednesday? ↗
Via Chartmill
Monday's session: top gainers and losers in the dow jones index ↗
Via Chartmill
News headline image
2 Beaten-Down Stocks Worth Buying and Holding for the Next Decade ↗
These companies haven't said their last words. 
Via The Motley Fool
News headline image
Looking for a Dividend Stock That Can Weather a Downturn? Start With Johnson & Johnson. ↗
Even in a recession, there's strong demand for J&J's myriad of pharmaceutical and healthcare products. 
Via The Motley Fool
Topics Economy
News headline image
Is Buying Nike Stock Now a Brilliant Move or a Disaster Waiting to Happen? Here's the Answer and What to Do Next. ↗
For those waiting for a Nike turnaround, it looks like there's more waiting ahead. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.